Operating segment information (Tables)

12 Months Ended

Dec. 31, 2018

Disclosure Of Operating Segments [Abstract]

Detailed Report of Segments

For the year ended December 31, 2017:

	Investing segment			Operating segment		Inter-segment elimination			Total
Consolidated statement of operations and comprehensive income (loss)
Gross revenue	$	-		$	4,082	$	-		$	4,082
Share of income from investments in equity accounted investees		165			-		-			165
Unrealized change in fair value of biological assets (Note 6)		-			(7,637)		-			(7,637)
Cost of sales before fair value adjustments (Note 6)		-			2,040		-			2,040
Realized fair value adjustments on inventory sold in the year (Note 6)		-			2,449		-			2,449
Gain on other investments		4,858			-		-			4,858
Intercompany revenue		624			-		(624	)		-
Share-based payments		1,862			-		-			1,862
Interest expense		1			600		(475	)		126
Depreciation and amortization		71			470		-			541
Net income (loss)		(368	)		3,382		(523	)		2,491
Consolidated statement of financial position
Total assets	$	151,998		$	70,198	$	(121,167	)	$	101,029
Total liabilities		979			67,957		(54,275	)		14,661
Shareholders' equity	$	151,019		$	2,241	$	(66,892	)	$	86,368
Other information
Property, plant and equipment	$	1,153		$	53,175	$	1,844		$	56,172
Additions to property, plant and equipment		139			42,908		-			43,046